Daniel Kracov, J.D.

Daniel Kracov is a Partner and Head of the FDA and Healthcare Regulatory Practice Group at Arnold & Porter LLP. He assists clients, including start-up companies, trade associations, and large manufacturing companies, in negotiating the legal requirements relating to the development, approval and marketing of drugs, biologics, medical devices and diagnostics. Mr. Kracov regularly represents clients in complex compliance challenges, enforcement actions, product-related crises, FDA and Congressional investigations, and legislative initiatives. He also conducts internal investigations, and assists in the development of corporate compliance programs. His expertise in strategic advice and crisis management won him as poton the Legal Timeslist of “Leading Lawyers in Food & Drug Law.”